Update of Recent Reforms in Germany to Enhance the Quality and Efficiency of Prescribing of Proton Pump Inhibitors and Lipid-Lowering Drugs

Author： Godman Brian   Schwabe Ulrich  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.5, 2009-05, pp. : 435-438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging lipid-lowering drugs: squalene synthase inhibitors

By Elsayed Raghda K   Evans Jeffery D  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 309-322

Informa Healthcare

Access to resources Recommend Favorite

Update on the pharmacogenomics of proton pump inhibitors

By Hagymáási Krisztina   Müüllner Katalin   Herszéényi Láászlóó   Tulassay Zsolt  

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 873-888

Future Medicine

Access to resources Recommend Favorite

New prospects for lipid-lowering drugs

By Thompson G.R.   Naoumova R.P.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 715-727

Informa Healthcare

Access to resources Recommend Favorite

Patients are less likely to receive lipid-lowering drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

A New Class of Lipid-Lowering Drugs: Ezetimibe

By  

Heart Drug, Vol. 3, Iss. 4, 2004-02 ,pp. : 214-216

Karger

Access to resources Recommend Favorite